ENP Newswire -
Release date- 27082014 -
Both companies will become part of Roper's Medical and Scientific Imaging segment.
SHP, headquartered in
IPA, headquartered in
'We are pleased to add these two outstanding businesses to our growing Medical platform,' said
'SHP's leading SaaS analytics platform expands our position and provides new opportunities in alternate site healthcare markets, further building on the positive momentum from last year's acquisition of
Including the previously announced
The information provided in this press release contains forward looking statements within the meaning of the federal securities laws. These forward looking statements include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth and profit expectations.
Forward looking statements may be indicated by words or phrases such as 'anticipate,' 'estimate,' 'plans,' 'expects,' 'projects,' 'should,' 'will,' 'believes' or 'intends' and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward looking statement. Such risks and uncertainties include our ability to integrate our acquisitions and realize expected synergies.
We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions, unfavorable changes in foreign exchange rates, difficulties associated with exports, risks associated with our international operations, difficulties in making and integrating acquisitions, risks associated with newly acquired businesses, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, environmental compliance costs and liabilities, risks and cost associated with asbestos related litigation and potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products.
Important risks may be discussed in current and subsequent filings with the
Most Popular Stories
- Alabama House Speaker Arrested on Felony Ethics Charges
- Microsoft's Cloud Platform Shines
- 'Fury' Blows 'Gone Girl' Out of the Box Office
- Turkey to Help Kurds Reach Fight in Kobani
- ISIS Seeks to Expand Terror War
- German Intelligence Blames Ukraine Rebels for MH17
- Perez Leads Push for Obama's Job Proposals
- 2016 Camaro Shrinks, Moves to Caddy Platform
- New Effort to Ban Child Labor From Tobacco Farms
- Prius Drivers Battle Stereotypes